Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study-Reference-Cited by-同舟云学术

Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study

Published:2018-01-12 Issue:5 Volume:107 Page:586-595
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Shimada Akira^ORCID,Iijima-Yamashita Yuka,Tawa Akio,Tomizawa Daisuke,Yamada Miho,Norio Shiba,Watanabe Tomoyuki,Taga Takashi,Iwamoto Shotaro,Terui Kiminori,Moritake Hiroshi,Kinoshita Akitoshi,Takahashi Hiroyuki,Nakayama Hideki,Koh Katsuyoshi,Goto Hiroaki,Kosaka Yoshiyuki,Saito Akiko Moriya,Kiyokawa Nobutaka,Horibe Keizo,Hara Yusuke,Oki Kentaro,Hayashi Yasuhide,Tanaka Shiro,Adachi Souichi

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/s12185-017-2395-x/fulltext.html

Reference26 articles.

1. Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK, et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood. 2001;97:89–94.

2. Zwaan CM, Meshinchi S, Radich JP, Veerman AJ, Huismans DR, Munske L, et al. FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood. 2003;102:2387–94.

3. Staffas A, Kanduri M, Hovland R, Rosenquist R, Ommen HB, Abrahamsson J, et al. Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia. Blood. 2011;118:5905–13.